Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse
Karinna Almodovar(Vanderbilt University Medical Center), Christine M. Lovly(Dana-Farber Cancer Institute), Yu Shyr(Vanderbilt University), Leora Horn(Vanderbilt University), Lee P. Lim, Sally J. York(Vanderbilt University Medical Center), Yingjun Yan(Vanderbilt University Medical Center), Heidi Chen(Vanderbilt University Medical Center), Christopher K. Raymond(Bellevue Hospital Center), Jennifer Hernandez, Wade T. Iams(Vanderbilt University Medical Center), Zhiguo Zhao(Vanderbilt University), Catherine B. Meador(Vanderbilt University Medical Center)
Cited by 137
Related Papers
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
|Cancer Cell|2004|1.1k
Mechanisms of receptor tyrosine kinase activation in cancer
|Molecular Cancer|2018|1.1k